2nd December 2020
Cambridge, UK – 2 December 2020: Nuformix plc (LSE:NFX; “Nuformix”, the “Company” or the “Group”), a drug re-purposing specialist, is pleased to announce that Madeleine “Maddy” Kennedy, FCCA, will join the Board of Nuformix as a Non-Executive Director with immediate effect. Maddy will be appointed as Chair of the Audit Committee. Download News